Tapewire

NYSE · USD

FLS

FLOWSERVE CORP

Export transactions ↓
Tapewire entity
3541
SEC CIK
0000030625
Parsed reports
537

Last 12 months

Inside the activity.

2 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202620
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Rowe Robert ScottDirector · President & CEO
Exercise / conversionPerformance Rights · Derivative 67,414 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · derivative · entry 5

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,162

Underlying: Common Stock · 67,414 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period.

F4 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period.

F4 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Rowe Robert ScottDirector · President & CEO
GrantRestricted Stock Units · Derivative 50,456 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · derivative · entry 4

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,843

Underlying: Common Stock · 50,456 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

F3 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

F3 · derivative.underlying: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Rowe Robert ScottDirector · President & CEO
GrantPerformance Rights · Derivative 61,669 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · derivative · entry 3

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 322,576

Underlying: Common Stock · 61,669 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Rowe Robert ScottDirector · President & CEO
Tax withholdingCommon Stock 28,328 $62.00 $1,756,336.00
Disclosure

SEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · nonDerivative · entry 2

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 393,389

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Rowe Robert ScottDirector · President & CEO
Exercise / conversionCommon Stock 71,995 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000013 · wk-form4_1739914155.xml · nonDerivative · entry 1

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 421,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 210 shares of the issuer's common stock acquired under the Flowserve Employee Stock Purchase Plan in monthly transactions that were exempt under Rule 16b-3.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Wilson KirkPresident, FCD
Exercise / conversionPerformance Rights · Derivative 7,035 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · derivative · entry 5

Wilson Kirk · CIK 0001654776 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,746

Underlying: Common Stock · 7,035 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period.

F4 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period.

F4 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate of 76.7% (plus dividends accrued on the underlying shares) based on two factors during the three-year performance cycle beginning on January 1, 2022 and ending on December 31, 2024, which are: 1) the issuer's free cash flow ("FCF") as a percent of adjusted net income for the performance period in comparison to the issuer's targeted free cash flow as a percent of adjusted net income for the performance period; and 2) the issuer's return on invested capital ("ROIC") for each calendar year in the performance period measured against the issuer's targeted ROIC for each calendar year under its operating plan. The performance rights were also subject to a 15% payout modifier (positive or negative) based on the issuer's total shareholder return ("TSR") in comparison to the TSR of peer companies for the entire performance period.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Wilson KirkPresident, FCD
GrantRestricted Stock Units · Derivative 5,606 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · derivative · entry 4

Wilson Kirk · CIK 0001654776 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,028

Underlying: Common Stock · 5,606 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

F3 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Wilson KirkPresident, FCD
GrantPerformance Rights · Derivative 5,606 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · derivative · entry 3

Wilson Kirk · CIK 0001654776 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,781

Underlying: Common Stock · 5,606 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Wilson KirkPresident, FCD
Tax withholdingCommon Stock 2,964 $62.00 $183,768.00
Disclosure

SEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · nonDerivative · entry 2

Wilson Kirk · CIK 0001654776 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,424

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:29 UTC
Wilson KirkPresident, FCD
Exercise / conversionCommon Stock 7,513 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000011 · wk-form4_1739914132.xml · nonDerivative · entry 1

Wilson Kirk · CIK 0001654776 · President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,388

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 43 shares of the issuer's common stock acquired under the Flowserve Employee Stock Purchase Plan in monthly transactions that were exempt under Rule 16b-3.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:28 UTC
Boukalik BrianChief Human Resources Officer
GrantRestricted Stock Units · Derivative 5,205 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000010 · wk-form4_1739914122.xml · derivative · entry 2

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,030

Underlying: Common Stock · 5,205 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:28 UTC
Boukalik BrianChief Human Resources Officer
GrantPerformance Rights · Derivative 5,205 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000010 · wk-form4_1739914122.xml · derivative · entry 1

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,986

Underlying: Common Stock · 5,205 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:28 UTC
VOPNI SCOTT KChief Accounting Officer
GrantRestricted Stock Units · Derivative 3,569 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000009 · wk-form4_1739914111.xml · derivative · entry 2

VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,714

Underlying: Common Stock · 3,569 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2025.

Read SEC document
February 13, 2025 Filed Feb 18, 2025 21:28 UTC
VOPNI SCOTT KChief Accounting Officer
GrantPerformance Rights · Derivative 1,529 $0.00 $0.00
Disclosure

SEC source: 0000030625-25-000009 · wk-form4_1739914111.xml · derivative · entry 1

VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,845

Underlying: Common Stock · 1,529 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2025 and ending on December 31, 2027 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

Read SEC document
February 03, 2025 Filed Nov 3, 2025 23:06 UTC
Rowe Robert ScottDirector · President & CEO
GrantCommon Stock 102 $62.62 $6,387.24
Disclosure

SEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 3

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443,925

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
February 03, 2025 Filed Nov 3, 2025 22:59 UTC
Wilson KirkFormer President, FCD
GrantCommon Stock 21 $62.62 $1,315.02
Disclosure

SEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 3

Wilson Kirk · CIK 0001654776 · Former President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,180

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
January 02, 2025 Filed Nov 3, 2025 23:06 UTC
Rowe Robert ScottDirector · President & CEO
GrantCommon Stock 74 $57.52 $4,256.48
Disclosure

SEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 2

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443,823

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
January 02, 2025 Filed Nov 3, 2025 22:59 UTC
Wilson KirkFormer President, FCD
GrantCommon Stock 15 $57.52 $862.80
Disclosure

SEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 2

Wilson Kirk · CIK 0001654776 · Former President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,159

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
December 02, 2024 Filed Nov 3, 2025 23:06 UTC
Rowe Robert ScottDirector · President & CEO
GrantCommon Stock 34 $61.02 $2,074.68
Disclosure

SEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 1

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443,749

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
December 02, 2024 Filed Nov 3, 2025 22:59 UTC
Wilson KirkFormer President, FCD
GrantCommon Stock 7 $61.02 $427.14
Disclosure

SEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 1

Wilson Kirk · CIK 0001654776 · Former President, FCD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,144

F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 21:14 UTC GiftCommon Stock 1,700 $0.00 $0.00
Disclosure

SEC source: 0000030625-24-000102 · wk-form4_1731446080.xml · nonDerivative · entry 1

DELLY GAYLA J · CIK 0001218358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,897

F1 · shares: On November 11, 2024, the reporting person made a charitable gift of 1,700 shares of Common Stock. No shares were sold.

Read SEC document
November 06, 2024 Filed Nov 6, 2024 22:18 UTC GrantPhantom Stock · Derivative 509 $59.24 $30,153.16
Disclosure

SEC source: 0000030625-24-000100 · wk-form4_1730931506.xml · derivative · entry 1

SIEGEL KENNETH I · CIK 0001465558 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,238

Underlying: Common Stock · 509 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
November 06, 2024 Filed Nov 6, 2024 22:18 UTC GrantPhantom Stock · Derivative 509 $59.24 $30,153.16
Disclosure

SEC source: 0000030625-24-000099 · wk-form4_1730931496.xml · derivative · entry 1

Taylor Carlyn R. · CIK 0001821412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,626

Underlying: Common Stock · 509 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
November 06, 2024 Filed Nov 6, 2024 22:18 UTC GrantPhantom Stock · Derivative 103 $59.24 $6,101.72
Disclosure

SEC source: 0000030625-24-000098 · wk-form4_1730931485.xml · derivative · entry 1

CHANDY RUBY R · CIK 0001358419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,594

Underlying: Common Stock · 103 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
November 06, 2024 Filed Nov 6, 2024 22:18 UTC GrantPhantom Stock · Derivative 509 $59.24 $30,153.16
Disclosure

SEC source: 0000030625-24-000097 · wk-form4_1730931474.xml · derivative · entry 1

Johnson Cheryl H · CIK 0001552649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,626

Underlying: Common Stock · 509 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 20:12 UTC GrantPhantom Stock · Derivative 124 $49.04 $6,080.96
Disclosure

SEC source: 0000030625-24-000089 · wk-form4_1722543112.xml · derivative · entry 1

CHANDY RUBY R · CIK 0001358419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,491

Underlying: Common Stock · 124 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 20:11 UTC GrantPhantom Stock · Derivative 615 $49.04 $30,159.60
Disclosure

SEC source: 0000030625-24-000088 · wk-form4_1722543101.xml · derivative · entry 1

Johnson Cheryl H · CIK 0001552649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,117

Underlying: Common Stock · 615 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 20:11 UTC GrantPhantom Stock · Derivative 615 $49.04 $30,159.60
Disclosure

SEC source: 0000030625-24-000087 · wk-form4_1722543091.xml · derivative · entry 1

SIEGEL KENNETH I · CIK 0001465558 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,729

Underlying: Common Stock · 615 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 20:11 UTC GrantPhantom Stock · Derivative 615 $49.04 $30,159.60
Disclosure

SEC source: 0000030625-24-000086 · wk-form4_1722543080.xml · derivative · entry 1

Taylor Carlyn R. · CIK 0001821412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,117

Underlying: Common Stock · 615 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
May 28, 2024 Filed May 29, 2024 20:16 UTC
Boukalik BrianChief Human Resources Officer
GrantPerformance Rights · Derivative 3,781 $0.00 $0.00
Disclosure

SEC source: 0000030625-24-000078 · wk-form4_1717013786.xml · derivative · entry 3

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,781

Underlying: Common Stock · 3,781 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2024 and ending on December 31, 2026 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F3 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2024 and ending on December 31, 2026 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

F3 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2024 and ending on December 31, 2026 which are based equally on: 1) the issuer's ROIC for each calendar year in the performance period measured against the issuer's target ROIC for each calendar year in the performance period; and 2) the issuer's FCF as a percentage of adjusted net income for each calendar year in the performance period measured against the issuer's target FCF as a percentage of adjusted net income for each calendar year in the performance period. The performance rights are also subject to 15% payout modifier (positive or negative) based on the issuer's relative TSR in comparison to the TSR of companies that comprise the S&P 500 Industrials Index for the entire performance period.

Read SEC document
May 28, 2024 Filed May 29, 2024 20:16 UTC
Boukalik BrianChief Human Resources Officer
GrantRestricted Stock Units · Derivative 3,781 $0.00 $0.00
Disclosure

SEC source: 0000030625-24-000078 · wk-form4_1717013786.xml · derivative · entry 2

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,825

Underlying: Common Stock · 3,781 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on March 1, 2025.

F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on March 1, 2025.

F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on March 1, 2025.

Read SEC document
May 28, 2024 Filed May 29, 2024 20:16 UTC
Boukalik BrianChief Human Resources Officer
GrantRestricted Stock Units · Derivative 2,044 $0.00 $0.00
Disclosure

SEC source: 0000030625-24-000078 · wk-form4_1717013786.xml · derivative · entry 1

Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,044

Underlying: Common Stock · 2,044 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025.

F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025.

F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025.

Read SEC document
May 23, 2024 Filed May 23, 2024 21:53 UTC
Rowe Robert ScottDirector · President & CEO
SaleCommon Stock 40,182 $49.36 $1,983,383.52
Disclosure

SEC source: 0000030625-24-000074 · wk-form4_1716501182.xml · nonDerivative · entry 3

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,512

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.04 to $50.04, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 23, 2024 Filed May 23, 2024 21:53 UTC
Rowe Robert ScottDirector · President & CEO
SaleCommon Stock 17,549 $48.96 $859,199.04
Disclosure

SEC source: 0000030625-24-000074 · wk-form4_1716501182.xml · nonDerivative · entry 2

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,694

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.76 to $49.04, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 23, 2024 Filed May 24, 2024 20:51 UTC
Hudson Susan ClaireChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 703 $0.00 $0.00
Disclosure

SEC source: 0000030625-24-000076 · wk-form4_1716583884.xml · derivative · entry 3

Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,928

Underlying: Common Stock · 703 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant.

F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant.

F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant.

Read SEC document
May 23, 2024 Filed May 24, 2024 20:51 UTC
Hudson Susan ClaireChief Legal Officer
Tax withholdingCommon Stock 255 $48.86 $12,459.30
Disclosure

SEC source: 0000030625-24-000076 · wk-form4_1716583884.xml · nonDerivative · entry 2

Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,205

Read SEC document
May 23, 2024 Filed May 24, 2024 20:51 UTC
Hudson Susan ClaireChief Legal Officer
Exercise / conversionCommon Stock 737 $0.00 $0.00
Disclosure

SEC source: 0000030625-24-000076 · wk-form4_1716583884.xml · nonDerivative · entry 1

Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,460

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 22, 2024 Filed May 23, 2024 21:53 UTC
Rowe Robert ScottDirector · President & CEO
SaleCommon Stock 42,269 $49.98 $2,112,604.62
Disclosure

SEC source: 0000030625-24-000074 · wk-form4_1716501182.xml · nonDerivative · entry 1

Rowe Robert Scott · CIK 0001608962 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 407,243

F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.75 to $50.46, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:11 UTC GrantPhantom Stock · Derivative 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000068 · wk-form4_1715976679.xml · derivative · entry 1

Johnson Cheryl H · CIK 0001552649 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,502

Underlying: Common Stock · 3,210 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:12 UTC GrantPhantom Stock · Derivative 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000069 · wk-form4_1715976702.xml · derivative · entry 1

SIEGEL KENNETH I · CIK 0001465558 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,114

Underlying: Common Stock · 3,210 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:11 UTC GrantCommon Stock 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000067 · wk-form4_1715976656.xml · nonDerivative · entry 1

DELLY GAYLA J · CIK 0001218358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,597

F1 · shares: Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on May 16, 2025.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:10 UTC GrantPhantom Stock · Derivative 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000066 · wk-form4_1715976641.xml · derivative · entry 1

CHANDY RUBY R · CIK 0001358419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,367

Underlying: Common Stock · 3,210 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:10 UTC GrantPhantom Stock · Derivative 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000064 · wk-form4_1715976590.xml · derivative · entry 1

Roberts David E Jr · CIK 0001363218 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,283

Underlying: Common Stock · 3,210 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:09 UTC GrantPhantom Stock · Derivative 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000063 · wk-form4_1715976562.xml · derivative · entry 1

Taylor Carlyn R. · CIK 0001821412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,502

Underlying: Common Stock · 3,210 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:10 UTC GrantCommon Stock 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000065 · wk-form4_1715976612.xml · nonDerivative · entry 1

McMurray Michael C. · CIK 0001556386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,663

F1 · shares: Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on May 16, 2025.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:09 UTC
Chand SujeetDirector
GrantPhantom Stock · Derivative 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000062 · wk-form4_1715976516.xml · derivative · entry 1

Chand Sujeet · CIK 0001388884 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,754

Underlying: Common Stock · 3,210 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:08 UTC GrantCommon Stock 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000061 · wk-form4_1715976498.xml · nonDerivative · entry 1

Okray Thomas B · CIK 0001689107 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,663

F1 · shares: Represents the annual restricted stock grant for the director under the Flowserve Long-Term Incentive Plan. The shares vest on May 16, 2025.

Read SEC document
May 16, 2024 Filed May 17, 2024 20:08 UTC GrantPhantom Stock · Derivative 3,210 $49.84 $159,986.40
Disclosure

SEC source: 0000030625-24-000060 · wk-form4_1715976460.xml · derivative · entry 1

GARRISON JOHN L JR · CIK 0001656422 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,065

Underlying: Common Stock · 3,210 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
May 02, 2024 Filed May 2, 2024 20:41 UTC GrantPhantom Stock · Derivative 124 $47.10 $5,840.40
Disclosure

SEC source: 0000030625-24-000049 · wk-form4_1714682497.xml · derivative · entry 1

CHANDY RUBY R · CIK 0001358419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,157

Underlying: Common Stock · 124 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document
May 02, 2024 Filed May 2, 2024 20:41 UTC GrantPhantom Stock · Derivative 610 $47.10 $28,731.00
Disclosure

SEC source: 0000030625-24-000048 · wk-form4_1714682482.xml · derivative · entry 1

SIEGEL KENNETH I · CIK 0001465558 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,904

Underlying: Common Stock · 610 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.